CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2020

Rhea-AI Summary

CooperCompanies (NYSE: COO) announced that it will release its fourth quarter and full year 2020 financial results on December 3, 2020, at 4:15 PM ET. A conference call will follow at 5:00 PM ET to discuss these results and current developments. Participants can join via a dedicated dial-in number or through a live webcast on the CooperCompanies investor relations website. A recording of the call will be available until December 10, 2020. CooperCompanies operates two units: CooperVision and CooperSurgical, focusing on vision care and women's health, respectively.

Positive

• Scheduled release of Q4 and full year 2020 financial results indicates transparency and engagement with investors.
• The investor call provides an opportunity for stakeholders to gain insights into current corporate developments.

Negative

• None.

SAN RAMON, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 2020, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The live dial-in number for the call is 855-643-4430 (U.S.) / 707-294-1332 (International). The participant passcode for the call is “Cooper”. A simultaneous webcast of the call will be available through the “Investor Relations” section of the CooperCompanies website at http://investor.coopercos.com and a transcript of the call will be archived on this site for a minimum of 12 months.

A recording of the call will be available beginning at 8:00 PM ET on December 3, 2020 through December 10, 2020. To hear this recording, dial 855-859-2056 (U.S.) / 404-537-3406 (International) and enter code 5599209.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com

FAQ

When will CooperCompanies release its Q4 2020 financial results?

CooperCompanies will release its Q4 2020 financial results on December 3, 2020, at 4:15 PM ET.

How can I participate in the CooperCompanies conference call?

You can join the conference call by dialing 855-643-4430 (U.S.) or 707-294-1332 (International) on December 3, 2020, at 5:00 PM ET.

Is there a webcast for the financial results announcement from CooperCompanies?

Yes, a live webcast will be available through the 'Investor Relations' section of CooperCompanies’ website.

Will there be a recording of the CooperCompanies conference call?

Yes, a recording of the conference call will be available from December 3, 2020, at 8:00 PM ET until December 10, 2020.

What business units does CooperCompanies operate?

CooperCompanies operates through two business units: CooperVision, focusing on vision care, and CooperSurgical, focusing on women's health.